Shoichi Mizuno

3.4k citations
103 papers · 2.6k indexed · h-index 27

Shoichi Mizuno

99 papers receiving 2.5k citations

Peers

Shoichi Mizuno
Comparison fields: 5 of 139
  • Pathology and Forensic Medicine 514
  • Oncology 705
  • Hepatology 155
  • Endocrinology, Diabetes and Metabolism 280
  • Immunology 316
Replace Keun‐Young Yoo with:
Keun‐Young Yoo South Korea
Unhee Lim United States
Youjin Je South Korea
Jin‐Hu Fan China
Chen Yuan China
Gabriele Nagel Germany
Veronika Fedirko United States
Haiping Mao China
Kyungdo Han South Korea
Chunfang Zhu China
Shoichi Mizuno relative to Keun‐Young Yoo South Korea Keun‐Young Yoo's profile →
Citations per field
00.5×1.6×
Keun‐Young Yoo · 1×
Citations per year

Countries citing papers authored by Shoichi Mizuno

Since Specialization
Citations

This map shows the geographic impact of Shoichi Mizuno's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shoichi Mizuno with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shoichi Mizuno more than expected).

Fields of papers citing papers by Shoichi Mizuno

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shoichi Mizuno. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shoichi Mizuno. The network helps show where Shoichi Mizuno may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Shoichi Mizuno, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Shoichi Mizuno Line = papers co-authored together Shoichi Mizuno links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20251
2 20241
3 20196
4 201820
5 201619
6 201439
7 201322
8 2012251
9 2009109
10 200517
11 200537
12 200332
13 200310
14 199724
15 199618
16 199476
17 199411
18 19935
19 198910
20 198919

About Shoichi Mizuno

Shoichi Mizuno is a scholar working on Oncology, Endocrinology, Diabetes and Metabolism and Pathology and Forensic Medicine, having authored 103 papers that have together received 2.6k indexed citations. Recurring topics across this work include Global Cancer Incidence and Screening (9 papers), Immunotherapy and Immune Responses (9 papers), Diet, Metabolism, and Disease (8 papers), Cancer Immunotherapy and Biomarkers (8 papers), Smoking Behavior and Cessation (7 papers), Phytoestrogen effects and research (7 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (7 papers) and Diet and metabolism studies (6 papers). The work is most often cited by research in Pathology and Forensic Medicine (514 citations), Oncology (705 citations) and Hepatology (155 citations). Shoichi Mizuno has collaborated with scholars based in Japan, United Kingdom and United States. Frequent co-authors include Shaw Watanabe, Melissa K. Melby, Akiko Morimoto, Yuko Ohno, Yukako Tatsumi, Tetsuya Nakatsura, Toshiaki Yoshikawa, Kyoko Taku, Tomotaka Sobue and Yoshiko Ishimi. Their work appears in journals such as Cancer Science, Journal of Epidemiology, Japanese Journal of Clinical Oncology, International Journal of Cancer and Radiation Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026